← Home / Polyrizon Ltd. (PLRZ)
Stock Analysis

Polyrizon Ltd. (PLRZ)

PLRZ
PLRZ · Healthcare • Biotechnology
10.30 -1.81%
Track PLRZ in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when PLRZ price is:
52W Range Position
51%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-24 02:44 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and structural levels before acting.
⚖️
Fundamentals
Insufficient / Negative
Price Structure
Vulnerable
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
9.43
Break Above
No reliable confirmation level is currently available.
Not available
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
What's Driving PLRZ?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 9.43 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
No qualified technical setup is currently active.
RSI(14)
41.7
Price Chart
PLRZ — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-21
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$21.9M
Company size
EV
$5.9M
Debt-adjusted value
P/B
0.8
Low book multiple
EV/EBIT
-0.9
Not meaningful
P/FCF
-8.5
Not meaningful
FCF Yield
-11.74%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
Revenue Growth
Insufficient
Profitability
Negative
Cash Flow
Recovering
Balance Sheet
Strong
📈 Net Income
-177,000
↘ Negative
🧮 EPS (Basic)
-0.12
↘ Negative
Polyrizon Ltd.
Healthcare • Biotechnology